Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
EKSO BIONICS (EKSO)
NASDAQ:EKSO
EKSO BIONICS (EKSO) Stock Price & Analysis
500 Followers
EKSO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.62 - $3.13
Previous Close$1.45
Volume33.78K
Average Volume (3M)138.81K
Market Cap
$24.72M
Enterprise Value$23.90M
Total Cash (Recent Filing)$9.94M
Total Debt (Recent Filing)$7.48M
Price to Earnings (P/E)-1.5
Beta1.08
Next Earnings
Jul 25, 2024EPS Estimate
-$0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.97
Shares Outstanding18,174,426
10 Day Avg. Volume50,016
30 Day Avg. Volume138,806
Standard Deviation0.28
R-Squared0.10
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)3.62
Price to Sales (P/S)1.91
Price to Cash Flow (P/CF)-4.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.86
Enterprise Value/Gross Profit3.85
Enterprise Value/Ebitda-1.79
Forecast
1Y Price Target
$10.00Price Target Upside635.29% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EKSO BIONICS News
Bulls Say, Bears Say
Bulls Say
Analyst RecommendationAnalyst maintains a Buy rating for EKSO with an optimistic 12-month price target based on comprehensive valuation methods.
International Market ExpansionRevenue growth in international markets, particularly EMEA, is being fueled by a strong increase in adoption in France.
Product ReimbursementThe Ekso Indego Personal has secured a favorable reimbursement price, potentially boosting its market adoption rates.
Bears Say
Earnings ReportThe company reported revenues significantly below the analyst's expectations, which could indicate underlying business challenges.
Regulatory SetbacksThe deferral by the Centers for Medicare & Medicaid Services on pricing could negatively impact the company's projected revenues and overall financial health.
Year-over-Year PerformanceThe company experienced a decline in revenues year-over-year, potentially signaling a concerning trend in its ability to generate sales.
---
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
EKSO FAQ
What was EKSO BIONICS’s price range in the past 12 months?
EKSO BIONICS lowest stock price was $0.62 and its highest was $3.13 in the past 12 months.
What is EKSO BIONICS’s market cap?
Currently, no data Available
When is EKSO BIONICS’s upcoming earnings report date?
EKSO BIONICS’s upcoming earnings report date is Jul 25, 2024 which is in 68 days.
How were EKSO BIONICS’s earnings last quarter?
EKSO BIONICS released its earnings results on Apr 29, 2024. The company reported -$0.2 earnings per share for the quarter, missing the consensus estimate of -$0.16 by -$0.04.
Is EKSO BIONICS overvalued?
According to Wall Street analysts EKSO BIONICS’s price is currently Undervalued.
Does EKSO BIONICS pay dividends?
EKSO BIONICS does not currently pay dividends.
What is EKSO BIONICS’s EPS estimate?
EKSO BIONICS’s EPS estimate is -$0.11.
How many shares outstanding does EKSO BIONICS have?
EKSO BIONICS has 18,174,425 shares outstanding.
What happened to EKSO BIONICS’s price movement after its last earnings report?
EKSO BIONICS reported an EPS of -$0.2 in its last earnings report, missing expectations of -$0.16. Following the earnings report the stock price went down -3.876%.
Which hedge fund is a major shareholder of EKSO BIONICS?
Currently, no hedge funds are holding shares in EKSO
---
EKSO BIONICS Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.00 (635.29% Upside)
$10.00 (635.29% Upside)
Insider Transactions
Bought Shares
Worth $15.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 2.2%
Last 30 Days ▲ 0.9%
Last 30 Days ▲ 0.9%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-16.04%
12-Months-Change
Fundamentals
Return on Equity
-80.59%
Trailing 12-Months
Asset Growth
-21.96%
Trailing 12-Months
Company Description
EKSO BIONICS
Ekso Bionics Holdings, Inc. engages in the design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. It operates through the following business segments: EksoHealth, EksoWorks, and Other. The EksoHealth segment consists of the engineering, manufacture, and sale of exoskeletons for applications in the medical markets. The EksoWorks segment offers exoskeleton devices to allow able-bodied users to perform heavy duty work for extended periods. The company was founded on January 30, 2012 and is headquartered in Richmond, CA.
---
EKSO Company Deck
---
EKSO Earnings Call
Q1 2024
0:00 / 0:00
---
EKSO Stock 12 Month Forecast
Average Price Target
$10.00
▲(635.29% Upside)
Technical Analysis
Best Analysts Covering EKSO
1 Year
1 Year Success Rate
2/11 ratings generated profit
1 Year Average Return
-24.26%
reiterated a buy rating 19 days ago
Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 18.18% of your transactions generating a profit, with an average return of -24.26% per trade.
---